Cravens & Co Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$913K Buy
2025
Q2
$636K Buy
2025
Q1
$627K Buy
2024
Q4
$673K Sell
2024
Q3
$964K Buy
2024
Q2
$1.14M Sell
2024
Q1
$1.06M Buy
2023
Q4
$845K Sell
2023
Q3
$745K Buy
2023
Q2
$657K Sell
2023
Q1
$845K Buy
2022
Q4
$718K Buy